Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
Maria Daniela Cirnaru, Antonella Marte, Elisa Belluzzi, et al.
Frontiers in Molecular Neuroscience (2014) Vol. 7
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
Mei Yue, Kelly M. Hinkle, Paul Davies, et al.
Neurobiology of Disease (2015) Vol. 78, pp. 172-195
Open Access | Times Cited: 232
Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
Mengru Liu, Siqi Liu, Zi-Han Lin, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 3
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate
Elisa Belluzzi, Adriano Gonnelli, Maria‐Daniela Cirnaru, et al.
Molecular Neurodegeneration (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 164
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 144
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
Amy R. Dunn, Kristen A. Stout, Minagi Ozawa, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 11
Open Access | Times Cited: 127
The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease
Jason Schapansky, Jonathan D. Nardozzi, Matthew J. LaVoie
Neuroscience (2014) Vol. 302, pp. 74-88
Open Access | Times Cited: 126
α-Synuclein – Regulator of Exocytosis, Endocytosis, or Both?
Janin Lautenschläger, Clemens F. Kaminski, Gabriele S. Kaminski Schierle
Trends in Cell Biology (2017) Vol. 27, Iss. 7, pp. 468-479
Open Access | Times Cited: 120
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
Isabella Russo, Giulia Berti, Nicoletta Plotegher, et al.
Journal of Neuroinflammation (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 114
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
Dayne Beccano-Kelly, Naila Kuhlmann, Igor Tatarnikov, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 109
Parkinson's disease: convergence on synaptic homeostasis
Sandra‐Fausia Soukup, Roeland Vanhauwaert, Patrik Verstreken
The EMBO Journal (2018) Vol. 37, Iss. 18
Open Access | Times Cited: 105
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
Kelly M. Lohr, Shababa T. Masoud, Ali Salahpour, et al.
European Journal of Neuroscience (2016) Vol. 45, Iss. 1, pp. 20-33
Open Access | Times Cited: 102
The associations between Parkinson’s disease and cancer: the plot thickens
Danielle Feng, Waijiao Cai, Xiqun Chen
Translational Neurodegeneration (2015) Vol. 4, Iss. 1
Open Access | Times Cited: 91
Promising drug targets and associated therapeutic interventions in Parkinson’s disease
Sachchida Nand, Payal Singh, Ritu Varshney, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 9, pp. 1730-1730
Open Access | Times Cited: 85
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
Shani Stern, Shong Lau, Andreea Manole, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient‐derived induced pluripotent stem cells
Mi‐Young Son, Helena Sim, Yebin Son, et al.
Neuropathology and Applied Neurobiology (2017) Vol. 43, Iss. 7, pp. 584-603
Closed Access | Times Cited: 76
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
Jean‐Marc Taymans, Elisa Greggio
Current Neuropharmacology (2016) Vol. 14, Iss. 3, pp. 214-225
Open Access | Times Cited: 73
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
Marian Blanca Ramírez, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 14, pp. 2747-2767
Open Access | Times Cited: 73
LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia
Judong Kim, Edward Pajarillo, Asha Rizor, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210248-e0210248
Open Access | Times Cited: 71
Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain
Laura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.
Journal of Neurochemistry (2015) Vol. 135, Iss. 6, pp. 1242-1256
Open Access | Times Cited: 66
Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease
Mattia Volta, Austen J. Milnerwood, Matthew J. Farrer
The Lancet Neurology (2015) Vol. 14, Iss. 10, pp. 1054-1064
Closed Access | Times Cited: 65
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors
Dan Dou, Jayne Aiken, Erika L.F. Holzbaur
The Journal of Cell Biology (2024) Vol. 223, Iss. 6
Open Access | Times Cited: 7
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Gaynor A. Smith, Johan Jansson, Emily M. Rocha, et al.
Molecular Neurobiology (2015) Vol. 53, Iss. 8, pp. 5161-5177
Open Access | Times Cited: 62
The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions
María Dolores Pérez‐Carrión, Silvia Marsicano, Federica Daniele, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 60
The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus
Eric S. Sweet, Bernardette T. Saunier-Rébori, Zhenyu Yue, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 32, pp. 11190-11195
Open Access | Times Cited: 58
Deregulation of autophagy and vesicle trafficking in Parkinson’s disease
Patricia Sheehan, Zhenyu Yue
Neuroscience Letters (2018) Vol. 697, pp. 59-65
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top